New Delhi, April 7 Aurobindo Pharma announced on Tuesday that it has received final approval from the US health regulator for its generic version of dapagliflozin tablets, which are used to control blood sugar levels in people with type 2 diabetes.The final approval granted by the US Food &...
New Delhi, March 31 Pharma major Lupin Ltd announced on Tuesday that it has received tentative approval from the US health regulator for its generic version of Sugammadex injection, used for reversing the effects of muscle relaxants administered during surgery.The tentative approval by the US...
New Delhi, March 25 Pharma major Lupin Ltd announced on Wednesday that it has received tentative approval from the US health regulator for its generic version of Pitolisant tablets, indicated for the treatment of excessive daytime sleepiness.The tentative approval from the US Food and Drug...
abbreviated new drug application
drug development
drug manufacturing
excessive daytime sleepiness
generic pharmaceuticals
healthcare
india
lupin ltd
nagpur
pharmaceuticalapprovalpharmaceutical industry
pitolisant
regulatory filings
tablet
us food and drug administration (usfda)